SILO - Silo Pharma, Inc.

📈 Is growth accelerating? 6 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2013 10-Q ↗	Q2 FY2017 Jun 30, 2013 10-Q ↗	Q1 FY2017 Mar 31, 2013 10-Q ↗	Q4 FY2016 Dec 31, 2012 10-K ↗	Q3 FY2016 Sep 30, 2012 10-Q ↗	Q2 FY2016 Jun 30, 2012 10-Q ↗	Q1 FY2016 Mar 31, 2012 10-Q ↗	Q4 FY2015 Dec 31, 2011 10-K ↗	Q3 FY2015 Sep 30, 2011 10-Q ↗	Q2 FY2015 Jun 30, 2011 10-Q ↗	Q1 FY2015 Dec 31, 2011 10-Q ↗	Q4 FY2014 Dec 31, 2010 10-K ↗	Q3 FY2014 Sep 30, 2010 10-Q ↗	Q2 FY2014 Dec 31, 2010 10-Q ↗	Q1 FY2014 Dec 31, 2010 10-Q ↗
Revenue Growth YoY (%)	N/M	0.0% Caution → Caution Stable Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-100%)	0.0% Caution → Caution Stable Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-100%)	0.0% Caution → Caution Stable Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-100%)	0.0% Caution → Caution Stable Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-100%)	0.0% Caution → Caution Stable Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-100%)	0.0% Caution → Caution Stable Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-100%)	0.0% Caution → Caution Stable Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-100%)	0.0% Caution Caution Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-100%)	—	0.0% Caution Caution Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-100%)	—	—	—	—	—	—	—	—	—	2972.4% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+37055%)	16033.7% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+200321%)	—	5976.5% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+74606%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
EPS Growth YoY (%)	-300.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	47.8% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	100.0% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	45.5% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	38.7% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	17.9% Good Good Year-over-year change in earnings per share Optimal: > 10%	-7.9% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	N/M	—	—	—	—	—	—	—	—	—	—	—	—	0.0% Caution Caution Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	-59.7% Weak ↓ Weak Declining Year-over-year change in net income	-59.7% Weak ↓ Weak Declining Year-over-year change in net income	49.1% Excellent ↑ Excellent Improving Year-over-year change in net income	-28.7% Weak ↑ Weak Improving Year-over-year change in net income	-28.7% Weak ↓ Weak Declining Year-over-year change in net income	-28.7% Weak ↓ Weak Declining Year-over-year change in net income	-54.4% Weak ↓ Weak Declining Year-over-year change in net income	11.6% Fair ↓ Fair Declining Year-over-year change in net income	11.6% Fair ↑ Fair Improving Year-over-year change in net income	11.6% Fair ↑ Fair Improving Year-over-year change in net income	32.6% Excellent ↑ Excellent Improving Year-over-year change in net income	-50.0% Weak ↓ Weak Declining Year-over-year change in net income	-37.7% Weak ↓ Weak Declining Year-over-year change in net income	-50.0% Weak ↓ Weak Declining Year-over-year change in net income	-52.7% Weak ↓ Weak Declining Year-over-year change in net income	35.1% Excellent ↑ Excellent Improving Year-over-year change in net income	-42.5% Weak ↓ Weak Declining Year-over-year change in net income	35.1% Excellent ↑ Excellent Improving Year-over-year change in net income	-37.8% Weak ↑ Weak Improving Year-over-year change in net income	-46.8% Weak ↑ Weak Improving Year-over-year change in net income	66.4% Excellent ↑ Excellent Improving Year-over-year change in net income	-289.6% Weak ↓ Weak Declining Year-over-year change in net income	-106.7% Weak ↑ Weak Improving Year-over-year change in net income	-138.7% Weak ↑ Weak Improving Year-over-year change in net income	-467.7% Weak ↓ Weak Declining Year-over-year change in net income	-93.4% Weak ↓ Weak Declining Year-over-year change in net income	19.2% Good ↑ Good Improving Year-over-year change in net income	-34.0% Weak Weak Year-over-year change in net income	23.3% Good Good Year-over-year change in net income	N/M	N/M	-3349.9% Weak Weak Year-over-year change in net income	-1305.5% Weak Weak Year-over-year change in net income	N/M	N/M	32.8% Excellent ↑ Excellent Improving Year-over-year change in net income	-296.6% Weak ↓ Weak Declining Year-over-year change in net income	-4.3% Weak ↓ Weak Declining Year-over-year change in net income	—	51.7% Excellent ↑ Excellent Improving Year-over-year change in net income	59.1% Excellent ↑ Excellent Improving Year-over-year change in net income	-9492.8% Weak Weak Year-over-year change in net income	—	-3837.6% Weak Weak Year-over-year change in net income	—	—	—	—	—	—
FCF Growth YoY (%)	—	83.6% Excellent Excellent Year-over-year change in free cash flow	—	—	—	-25.1% Weak Weak Year-over-year change in free cash flow	—	—	—	-33.3% Weak Weak Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	—	—	0.0% Weak Weak Compound annual revenue growth over 3 years	—	—	—	—	—	-35.8% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-27.6% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	—	3.4% Caution ↓ Caution Declining Compound annual revenue growth over 3 years	101.1% Excellent Excellent Compound annual revenue growth over 3 years	—	-23.5% Weak Weak Compound annual revenue growth over 3 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 5Y (%)	—	-17.6% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	—	2.1% Caution ↓ Caution Declining Compound annual revenue growth over 5 years	52.1% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	127.8% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	-14.9% Weak Weak Compound annual revenue growth over 5 years	132.0% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 2 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2013 10-Q ↗	Q2 FY2017 Jun 30, 2013 10-Q ↗	Q1 FY2017 Mar 31, 2013 10-Q ↗	Q4 FY2016 Dec 31, 2012 10-K ↗	Q3 FY2016 Sep 30, 2012 10-Q ↗	Q2 FY2016 Jun 30, 2012 10-Q ↗	Q1 FY2016 Mar 31, 2012 10-Q ↗	Q4 FY2015 Dec 31, 2011 10-K ↗	Q3 FY2015 Sep 30, 2011 10-Q ↗	Q2 FY2015 Jun 30, 2011 10-Q ↗	Q1 FY2015 Dec 31, 2011 10-Q ↗	Q4 FY2014 Dec 31, 2010 10-K ↗	Q3 FY2014 Sep 30, 2010 10-Q ↗	Q2 FY2014 Dec 31, 2010 10-Q ↗	Q1 FY2014 Dec 31, 2010 10-Q ↗
Effective Tax Rate (%) (%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-0.5% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.3% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
FCF / Net Income (x)	0.47x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.50x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.89x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.93x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	—	1.59x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	0.53x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	1.05x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	0.81x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.76x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.53x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	1.31x Good Good Free cash flow relative to reported net income Optimal: > 1x	0.71x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.34x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.68x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	0.49x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.77x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	1.21x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	0.34x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.25x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	-0.92x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	10.92x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	-0.00x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	—	1.84x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	0.07x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.41x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	0.06x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	—	1.00x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.75x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.00x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	—	1.00x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2013 10-Q ↗	Q2 FY2017 Jun 30, 2013 10-Q ↗	Q1 FY2017 Mar 31, 2013 10-Q ↗	Q4 FY2016 Dec 31, 2012 10-K ↗	Q3 FY2016 Sep 30, 2012 10-Q ↗	Q2 FY2016 Jun 30, 2012 10-Q ↗	Q1 FY2016 Mar 31, 2012 10-Q ↗	Q4 FY2015 Dec 31, 2011 10-K ↗	Q3 FY2015 Sep 30, 2011 10-Q ↗	Q2 FY2015 Jun 30, 2011 10-Q ↗	Q1 FY2015 Dec 31, 2011 10-Q ↗	Q4 FY2014 Dec 31, 2010 10-K ↗	Q3 FY2014 Sep 30, 2010 10-Q ↗	Q2 FY2014 Dec 31, 2010 10-Q ↗	Q1 FY2014 Dec 31, 2010 10-Q ↗
Return on Invested Capital (%)	-15.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-22.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-9.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-18.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-20.1% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-21.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-28.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-11.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-13.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-13.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-14.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-8.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-10.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-6.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-12.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-6.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-5.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-4.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-10.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-4.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-10.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-18.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-36.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-24.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-34.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	48.1% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	1116.2% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	189.1% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-145.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-47.1% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-58.6% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Return on Capital (%) (%)	-15.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-22.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-10.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-18.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-18.8% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-18.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-24.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-11.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-12.5% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-12.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-15.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-8.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-10.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-7.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-14.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-7.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-5.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-5.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-9.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-4.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-10.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-17.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-41.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-28.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-35.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-39.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-65.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-62.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-35.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-23.2% Weak Weak Operating profit relative to total assets Optimal: > 10%	-35.3% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Return on Common Equity (%) (%)	-33.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-325%)	-29.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-293%)	-14.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-193%)	-20.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-237%)	-21.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-240%)	-25.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-271%)	-34.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-329%)	-11.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-179%)	-13.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-190%)	-15.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-201%)	-18.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-221%)	-12.1% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-181%)	-10.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-173%)	-9.6% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-164%)	-16.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-207%)	-5.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-134%)	-8.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-156%)	-7.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-147%)	-12.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-180%)	-9.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-161%)	-12.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-182%)	-22.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-247%)	-61.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-511%)	-30.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-304%)	-59.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-498%)	91.3% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+508%)	—	262.1% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1647%)	-235.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1669%)	-42.2% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-381%)	-116.1% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-874%)	—	—	—	131.0% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+773%)	-1.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-107%)	-6.7% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-145%)	—	29.6% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+97%)	—	—	—	—	—	—	—	—	—	—	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2013 10-Q ↗	Q2 FY2017 Jun 30, 2013 10-Q ↗	Q1 FY2017 Mar 31, 2013 10-Q ↗	Q4 FY2016 Dec 31, 2012 10-K ↗	Q3 FY2016 Sep 30, 2012 10-Q ↗	Q2 FY2016 Jun 30, 2012 10-Q ↗	Q1 FY2016 Mar 31, 2012 10-Q ↗	Q4 FY2015 Dec 31, 2011 10-K ↗	Q3 FY2015 Sep 30, 2011 10-Q ↗	Q2 FY2015 Jun 30, 2011 10-Q ↗	Q1 FY2015 Dec 31, 2011 10-Q ↗	Q4 FY2014 Dec 31, 2010 10-K ↗	Q3 FY2014 Sep 30, 2010 10-Q ↗	Q2 FY2014 Dec 31, 2010 10-Q ↗	Q1 FY2014 Dec 31, 2010 10-Q ↗
Interest Coverage (x)	-324.24x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-472.77x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-24.05x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-1299.62x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	—	-529.58x Weak Weak Operating income divided by interest expense Optimal: > 5x	-6618.07x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	-470.33x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-4262.73x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-717.44x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-598.49x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-485.49x Weak Weak Operating income divided by interest expense Optimal: > 5x	-13807.98x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	-316.03x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	—	-72861.71x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-20597.94x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-12586.74x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-1618.88x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-5.36x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-1.93x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-374.37x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-2579.86x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-600.87x Weak Weak Operating income divided by interest expense Optimal: > 5x	-384.50x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Debt (USD)	$-3.28M	$-3.90M	$-4.75M	$-3.92M	$-4.33M	$-3.14M	$-3.91M	$-4.86M	$-4.51M	$-2.67M	$-3.52M	$-199.84K	$-158.83K	$-4.67M	$-11.37M	$-12.25M	$-8.73M	$-9.07M	$-9.84M	$-10.26M	$-4.15M	$-4.64M	$-1.13M	$-1.65M	$-1.92M	$-9.14K	$-111.75K	$-24.56K	$-76.97K	$-177.35K	$-336.68K	—	—	—	$-294.59K	$-1.26M	$-368.68K	$-10.10K	$-279.00	$-279.00	$-813.00	$-3.71K	$-1.75K	—	—	$-36.16K	$0.00	—	—	$0.00

📊 What does each share earn? 6 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2013 10-Q ↗	Q2 FY2017 Jun 30, 2013 10-Q ↗	Q1 FY2017 Mar 31, 2013 10-Q ↗	Q4 FY2016 Dec 31, 2012 10-K ↗	Q3 FY2016 Sep 30, 2012 10-Q ↗	Q2 FY2016 Jun 30, 2012 10-Q ↗	Q1 FY2016 Mar 31, 2012 10-Q ↗	Q4 FY2015 Dec 31, 2011 10-K ↗	Q3 FY2015 Sep 30, 2011 10-Q ↗	Q2 FY2015 Jun 30, 2011 10-Q ↗	Q1 FY2015 Dec 31, 2011 10-Q ↗	Q4 FY2014 Dec 31, 2010 10-K ↗	Q3 FY2014 Sep 30, 2010 10-Q ↗	Q2 FY2014 Dec 31, 2010 10-Q ↗	Q1 FY2014 Dec 31, 2010 10-Q ↗
Revenue per Share (USD)	$0.00	$0.00	—	$0.00	$0.00	$0.00	—	$0.00	$0.01	$0.01	—	$0.01	$0.01	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-0.76	$-0.12	$0.00	$-0.12	$-0.19	$-0.23	$-0.41	$-0.22	$-0.31	$-0.28	$-0.38	—	—	—	—	$-0.49	$-0.01	$-0.01	—	$0.06	—	—	$-0.01	—	—	—	—	$-0.01	$-0.01	$-0.01	—	$0.00	$-0.01	$0.00	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-0.71	$-0.06	—	$-0.10	—	$-0.37	—	—	—	$-0.29	—	—	—	$-0.22	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$4.33	$0.35	$0.47	$0.48	$0.57	$0.89	$1.12	$1.51	$1.60	$1.87	$2.13	$2.41	$2.67	$2.99	$3.27	$3.78	$0.08	$0.09	$4.59	$0.10	$0.04	$0.05	$0.02	$0.02	$0.03	$-0.01	$-0.00	$-0.00	$0.00	$0.01	$0.02	—	—	—	$0.02	$0.02	$0.01	$-0.00	$-0.00	—	—	—	$-0.00	—	—	—	—	—	—	—
Tangible Book Value per Share (USD)	$4.14	$0.34	$0.46	$0.46	$0.54	$0.84	$1.07	$1.46	$1.53	$1.87	$2.13	$2.41	$2.67	$2.99	$3.27	$3.78	$0.08	$0.09	$4.59	$0.10	$0.04	$0.05	$0.02	$0.02	$0.03	$-0.01	$-0.00	$-0.01	$0.00	$0.01	$0.02	—	—	—	$0.02	$0.02	$0.01	$-0.00	$-0.00	—	—	—	$-0.00	—	—	—	—	—	—	—
Basic Weighted Avg Shares (shares)	1.10M	13.71M	—	9.33M	6.28M	4.48M	—	4.30M	3.05M	2.87M	—	3.11M	3.15M	3.16M	—	2.00M	—	—	—	98.64M	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2013 10-Q ↗	Q2 FY2017 Jun 30, 2013 10-Q ↗	Q1 FY2017 Mar 31, 2013 10-Q ↗	Q4 FY2016 Dec 31, 2012 10-K ↗	Q3 FY2016 Sep 30, 2012 10-Q ↗	Q2 FY2016 Jun 30, 2012 10-Q ↗	Q1 FY2016 Mar 31, 2012 10-Q ↗	Q4 FY2015 Dec 31, 2011 10-K ↗	Q3 FY2015 Sep 30, 2011 10-Q ↗	Q2 FY2015 Jun 30, 2011 10-Q ↗	Q1 FY2015 Dec 31, 2011 10-Q ↗	Q4 FY2014 Dec 31, 2010 10-K ↗	Q3 FY2014 Sep 30, 2010 10-Q ↗	Q2 FY2014 Dec 31, 2010 10-Q ↗	Q1 FY2014 Dec 31, 2010 10-Q ↗
Working Capital (USD)	$4.65M	$6.10M	$6.74M	$5.46M	$5.32M	$4.42M	$5.46M	$7.22M	$6.41M	$6.00M	$6.91M	$8.24M	$9.06M	$10.22M	$11.14M	$12.60M	$8.68M	$9.33M	$9.91M	$11.02M	$4.71M	$5.15M	$1.28M	$1.96M	$2.72M	$138.23K	$377.11K	$69.26K	$273.50K	$463.23K	$578.00K	—	—	—	$1.60M	$543.62K	$333.45K	$-44.08K	—	$-14.01K	$-5.46K	$213.00	$-1.75K	—	—	$-1.75K	$47.48K	—	—	$47.48K
Total Equity (USD)	$4.89M	$5.68M	$6.31M	$5.01M	$4.92M	$4.01M	$5.03M	$6.78M	$5.96M	$5.29M	$6.18M	$7.50M	$8.30M	$9.44M	$10.34M	$11.85M	$7.87M	$8.50M	$9.06M	$10.15M	$3.77M	$4.23M	$1.28M	$2.07M	$2.30M	$-261.77K	$-22.89K	$-101.30K	$102.94K	$292.67K	$407.44K	—	—	—	$1.20M	$543.62K	$333.45K	$-44.08K	$-41.19K	—	—	—	$-1.75K	—	—	—	—	—	—	—

📋 What is driving earnings? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2013 10-Q ↗	Q2 FY2017 Jun 30, 2013 10-Q ↗	Q1 FY2017 Mar 31, 2013 10-Q ↗	Q4 FY2016 Dec 31, 2012 10-K ↗	Q3 FY2016 Sep 30, 2012 10-Q ↗	Q2 FY2016 Jun 30, 2012 10-Q ↗	Q1 FY2016 Mar 31, 2012 10-Q ↗	Q4 FY2015 Dec 31, 2011 10-K ↗	Q3 FY2015 Sep 30, 2011 10-Q ↗	Q2 FY2015 Jun 30, 2011 10-Q ↗	Q1 FY2015 Dec 31, 2011 10-Q ↗	Q4 FY2014 Dec 31, 2010 10-K ↗	Q3 FY2014 Sep 30, 2010 10-Q ↗	Q2 FY2014 Dec 31, 2010 10-Q ↗	Q1 FY2014 Dec 31, 2010 10-Q ↗
Sales/Revenue/Turnover (USD)	$0.00	$18.03K	$18.03K	$18.02K	$18.02K	$18.03K	$18.03K	$18.02K	$18.02K	$18.03K	$18.03K	$18.02K	$18.02K	—	$18.03K	—	—	—	—	—	$68.08K	$47.43K	—	$16.29K	$2.22K	$294.00	$40.30K	$268.00	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Income, GAAP (USD)	$-1.65M	$-1.65M	$-881.53K	$-1.03M	$-1.03M	$-1.03M	$-1.73M	$-801.67K	$-801.67K	$-801.67K	$-1.12M	$-906.40K	$-906.40K	$-906.40K	$-1.66M	$-604.07K	$-658.40K	$-604.07K	$-1.09M	$-930.70K	$-461.99K	$-930.70K	$-789.81K	$-633.79K	$-1.38M	$-238.88K	$-382.08K	$-265.48K	$-242.21K	$-123.52K	$-472.94K	$-198.16K	$-315.91K	$17.55K	$1.58M	$-5.74K	$-22.48K	$-1.19M	$-12.19K	$-8.55K	$-5.67K	$-1.14M	—	$-17.72K	$-13.85K	$-11.90K	—	$-450.00	$0.00	—
Operating Cash Flow (USD)	$-781.86K	$-822.62K	$-780.28K	$-955.49K	—	$-1.64M	$-917.43K	—	—	$-838.18K	$-910.01K	—	—	$-692.69K	$-885.99K	—	—	$-789.16K	$-773.87K	—	—	$-311.82K	$-536.32K	—	—	$-117.61K	$-292.80K	—	—	$-149.52K	$-158.89K	$-50.09K	$289.94K	$191.68K	$-7.10K	—	$-41.41K	$-81.46K	$-5.00K	—	—	$-62.85K	—	$-17.72K	$-10.35K	$-11.90K	—	$-450.00	—	—

Silo Pharma, Inc.

Analytical Summary

50-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare SILO with peers